Nordic Bioscience at the 7th Dermatology Drug Development Summit in 2023
We are pleased to announce that Nordic Bioscience's dermatology team will be participating in the 7th Dermatology Drug Development Summit for Inflammatory Skin Diseases. This prominent summit, dedicated to advancing treatment options across a spectrum of conditions including Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Prurigo Nodularis, and Vitiligo, returns for its 7th year as the largest industry-focused event in the field.
Our team is enthusiastic about engaging in discussions on potential collaborations and the intersection of fibrosis with inflammatory skin diseases.
Stay tuned for upcoming updates and exclusive information as we prepare for our involvement in the 7th Dermatology Drug Development Summit. For the latest information, follow us on LinkedIn and Twitter. We look forward to contributing to the advancement of treatment options in this dynamic field.
